Product Information
ECONTRA ONE-STEP 1.5 MG TABLET is a generic product labeled by Afaxys Pharma, LLC, priced at $6.3305 per EA under NDC 50102021113. Its NADAC has been published 278 times since Jun 9, 2021.
FDA first approved this application on Dec 8, 2015.
Strength
1.5 mg/1
Manufacturer
Afaxys Pharma, LLCNDC
50102021113
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVONORGESTRELApproval Type
Generic (ANDA)
FDA Application
ANDA206867FDA Approved
12/8/2015
On Market Since
2/8/2018
Pharmacological Classes
Price Statistics
The NADAC for ECONTRA ONE-STEP 1.5 MG TABLET has been published 278 times since Jun 9, 2021, and over the history we have for it it has declined 27.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.3305 per EA |
|---|---|
| All-time high | $10.2150 (Apr 13, 2022) |
| All-time low | $5.2568 (Nov 20, 2024) |
| 52-week high | $6.8109 |
| 52-week low | $6.2162 |
| Median price | $6.8124 |
| Average price | $7.4506 |
| Largest weekly change | -18.7% (Nov 20, 2024) |
| Weeks tracked | 278 |
| Tracking since | Jun 9, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Afaxys Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levonorgestrel market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progestin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ECONTRA ONE-STEP 1.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ECONTRA ONE-STEP 1.5 MG TABLET, manufactured by Afaxys Pharma, LLC, is $6.3305 per EA (NDC 50102021113), effective Sep 30, 2026.
How has the price of ECONTRA ONE-STEP 1.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ECONTRA ONE-STEP 1.5 MG TABLET has declined 27.2%. It has been tracked across 278 weekly CMS publications since Jun 9, 2021.
What are the highest and lowest recorded NADAC prices for ECONTRA ONE-STEP 1.5 MG TABLET?
Since Jun 9, 2021, the NADAC for ECONTRA ONE-STEP 1.5 MG TABLET has ranged from a low of $5.2568 (Nov 20, 2024) to a high of $10.2150 (Apr 13, 2022), with a median of $6.8124 per EA.
Are there cheaper alternatives to ECONTRA ONE-STEP 1.5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ECONTRA ONE-STEP 1.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ECONTRA ONE-STEP 1.5 MG TABLET?
ECONTRA ONE-STEP 1.5 MG TABLET (NDC 50102021113) is labeled by Afaxys Pharma, LLC, and CMS classifies it as a generic product.